ProteoNova has created the AcPET system, a platform technology with the ability to address both the increasing cost and the increasing timeline for new product development's discovery and pre-clinical stages. This transformative technology will be able to reduce the out-of-pocket cost for each drug candidate to a few million dollars and thetimeline to a few weeks. The cost and time to develop a single protein-based therapeutic, from discovery to FDA submission, is enormous and continues to rise.

Biotechnology

ProteoNova

ProteoNova's headquarters in Pasadena, CA, United States

Robert R. Guerrero

Richard B. Williams

Description

People (1)

Robert R. Guerrero

Jobs